Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.

Journal of advanced research·2023
Same author

Recommendations for Early and Comprehensive Management of Type 2 Diabetes and Its Related Cardio-Renal Complications.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2022
Same author

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases.

Biomedicines·2021
Same author

Diabetic Nephropathy and COVID-19: The Potential Role of Immune Actors.

International journal of molecular sciences·2021
Same author

Characteristics and treatment patterns of patients with type 2 diabetes in Lebanon: the DISCOVER study.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit·2021
Same author

Immune Checkpoint Inhibitor-Induced Diabetes Mellitus: Potential Role of T Cells in the Underlying Mechanism.

International journal of molecular sciences·2021
Same journal

The Need for Community-Based Multimodal Screening for Chronic Disease and Cancer in Rural Kansas.

International journal of general medicine·2026
Same journal

Awareness and Understanding of Ionizing and Non-Ionizing Radiation Modalities Among Patients in Saudi Arabia.

International journal of general medicine·2026
Same journal

Development and Validation of an Interpretable Machine Learning Model Based on Peripheral Blood Biomarkers for Esophageal Cancer Risk Prediction.

International journal of general medicine·2026
Same journal

Screening for Abdominal Aortic Aneurysm in Elderly Male Patients with Coronary Artery Disease During Standard Transthoracic Echocardiography.

International journal of general medicine·2026
Same journal

Machine Learning-Based Prediction Model for Type 2 Diabetic Peripheral Neuropathy: Role of Bilateral Brachial-Ankle Pulse Wave Velocity and Anthropometric Indicators.

International journal of general medicine·2026
Same journal

Clinical Characteristics and Independent Risk Factors of Primary Gastrointestinal Lymphoma Complicated with Gastrointestinal Complications.

International journal of general medicine·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Thyroid dysfunction in pregnancy.

Khalid A El Baba1, Sami T Azar

  • 1Department of Internal Medicine, Division of Endocrinology, Bahrain Specialist Hospital, Manama, Bahrain.

International Journal of General Medicine
|March 16, 2012
PubMed
Summary
This summary is machine-generated.

Timely management of thyroid dysfunction during pregnancy is crucial for preventing adverse maternal and fetal outcomes. Early screening and accurate interpretation of thyroid hormone levels, including thyroid-stimulating hormone (TSH), are vital for healthy pregnancy.

Keywords:
HCGTBGTSH

Related Experiment Videos

Last Updated: May 24, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

Area of Science:

  • Endocrinology
  • Maternal-Fetal Medicine
  • Reproductive Health

Background:

  • Thyroid dysfunction in pregnancy poses risks to both mother and fetus.
  • Subclinical thyroid abnormalities often require specific screening for detection.
  • Maternal thyroid hormone deficiency can impact fetal neurodevelopment.

Purpose of the Study:

  • To highlight the importance of managing thyroid dysfunction during pregnancy.
  • To emphasize the need for accurate diagnosis and treatment protocols.
  • To discuss strategies for preventing maternal and fetal complications.

Main Methods:

  • Measurement of serum thyroid-stimulating hormone (TSH) and free thyroxine levels.
  • Utilizing gestation-age-specific TSH thresholds for diagnosis.
  • Review of current literature on thyroid hormone management in pregnancy.

Main Results:

  • Accurate diagnosis relies on TSH and free thyroxine measurements.
  • Gestation-age-specific TSH thresholds aid in diagnosis.
  • Need for pregnancy-specific free thyroxine thresholds identified.

Conclusions:

  • Timely intervention for thyroid disorders in pregnancy is essential.
  • Screening programs and accurate interpretation of thyroid hormones are critical.
  • Further research, including large-scale trials, is needed to evaluate screening efficacy.